TNNI3 and substance withdrawal syndrome: During the morphine withdrawal syndrome, there is an increase in cardiac troponin T (cTnT) expression together with a decrease in cardiac troponin I (cTnI) expression, and a co-localization between cTnT and HSP-27 which has been described by immunofluorescence [75].